{"id":"W4400327380","doi":"10.1007/s11523-024-01074-9","title":"A Podcast on Platinum Eligibility and Treatment Sequencing in Platinum-Eligible Patients with Locally Advanced or Metastatic Urothelial Carcinoma","year":2024,"lang":"en","type":"article","venue":"Targeted Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Carboplatin; Metastatic Urothelial Carcinoma; Pembrolizumab; Oncology; Internal medicine; Cisplatin; Chemotherapy; Nivolumab; Avelumab; Atezolizumab; Urothelial carcinoma; Immunotherapy; Cancer; Bladder cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001202761,0.0003666337,0.000690099,0.0002486366,0.00006763618,0.00002359498,0.00005598694,0.0001213472,0.0002306832],"category_scores_gemma":[0.00005948126,0.000226637,0.00006469822,0.0003538099,0.0001136289,0.0001061372,0.00002682076,0.0002486426,0.00004272036],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002772538,"about_ca_system_score_gemma":0.002186014,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009693079,"about_ca_topic_score_gemma":0.001492662,"domain_scores_codex":[0.9980687,0.0001139159,0.0004180355,0.0006784235,0.0002570801,0.000463812],"domain_scores_gemma":[0.9991016,0.0002797887,0.00007100544,0.000275914,0.00007128734,0.0002004034],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.08318335,0.004356073,0.4268741,0.001120581,0.002029351,0.01112986,0.01665256,0.001413583,0.008780695,0.0005932934,0.0006140022,0.4432526],"study_design_scores_gemma":[0.1626532,0.2298631,0.536244,0.002506453,0.002777741,0.001031009,0.00313424,0.01092577,0.02377556,0.001894743,0.02279602,0.002398186],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942355,0.0004975561,0.00006603701,0.0002606698,0.0002104091,0.001850697,0.0001635579,0.0001146669,0.002600904],"genre_scores_gemma":[0.9959762,0.00005660579,0.002528575,0.0004384153,0.00007868801,0.0002754908,0.000104353,0.00005519229,0.0004865448],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4408544,"threshold_uncertainty_score":0.9241987,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02966134817079552,"score_gpt":0.3259758250055169,"score_spread":0.2963144768347213,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}